Noé Brasier

Noé Brasier, MD, is a board-certified internist (FMH, Swiss Medical Association) with a medical doctorate from the University of Basel (CH), where he investigated the clinical validity of a smartphone camera algorithm for detecting atrial fibrillation – the most common arrhythmia linked to stroke. Driven by curiosity and medical need, he later turned his research from physical wearables for vital sign monitoring toward translation of sweat analysis by wearable devices, working at the intersection of engineering and early clinical adoption.
After completing his clinical training, Dr. Brasier received the prestigious MedLab Fellowship at ETH Zurich (Zurich, CH) and an Early-Career Fellowship at Collegium Helveticum (Zurich, CH), where he laid the groundwork for translational concepts in sweat-based biomarker discovery, wearable sensing, and clinical implementation. He now serves as principal investigator of the AGE RESIST project, a joint Swiss-U.S. initiative supported by the Swiss National Science Foundation and the U.S. National Science Foundation investigating a novel age clock of resilience from sweat. This work is a collaborative effort between ETH Zurich, California Institute of Technology, Swiss Federal Laboratories of Materials Science and Technology (Empa), and Felix-Platter Hospital, a leading hospital for geriatric medicine in Switzerland.
At ETH Zurich’s Department of Health Sciences and Technology, Dr. Brasier lectures on translational medicine and created the new “Digital Biomarkers” course for medical students, introducing future doctors to digital health and wearable sensing. He also founded the Next-generation Digital Biomarkers Summit, now in its third edition in 2025, and set to become a Nature Conference in 2027, bringing global leaders together to advance clinical translation and implementation of digital biomarkers. Finally, Dr. Brasier is an expert monitor for the prestigious pathfinder challenge by the European Innovation Council.